Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Disease Progression and IDH2[original query] |
|---|
| IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. American journal of hematology 2014 Feb 89 (2): 137-44. Lin Chien-Chin, Hou Hsin-An, Chou Wen-Chien, Kuo Yuan-Yeh, Liu Chieh-Yu, Chen Chien-Yuan, Lai Yan-Jun, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Ko Bor-Sheng, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
| Prognostic value of isocitrate dehydrogenase mutations in myelodysplastic syndromes: a retrospective cohort study and meta-analysis. PloS one 2014 9 (6): e100206. Jin Jie, Hu Chao, Yu Mengxia, Chen Feifei, Ye Li, Yin Xiufeng, Zhuang Zhengping, Tong Hongy |
| Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia. Oncotarget 2016 Jan . Hou Hsin-An, Liu Chieh-Yu, Kuo Yuan-Yeh, Chou Wen-Chien, Tsai Cheng-Hong, Lin Chien-Chin, Lin Liang-In, Tseng Mei-Hsuan, Chiang Ying-Chieh, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Li Chi-Cheng, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Chen Chien-Yuan, Lin Chien-Ting, Wu Shang-Ju, Tsay Woei, Tien Hwei-Fa |
| Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome. Clinical epigenetics 2018 4 10 42. Lin Ming-En, Hou Hsin-An, Tsai Cheng-Hong, Wu Shang-Ju, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Liu Ming-Chih, Liu Chia-Wen, Chou Wen-Chien, Chen Chien-Yuan, Tang Jih-Luh, Yao Ming, Li Chi-Cheng, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Lin Chien-Ting, Tien Hwei-Fa |
| Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3. Cancer 2019 10 126 (2): 344-353. Zhang Chunxiao, Lam Stephen S Y, Leung Garret M K, Tsui Sze-Pui, Yang Ning, Ng Nelson K L, Ip Ho-Wan, Au Chun-Hang, Chan Tsun-Leung, Ma Edmond S K, Yip Sze-Fai, Lee Harold K K, Lau June S M, Luk Tsan-Hei, Li Wa, Kwong Yok-Lam, Leung Anskar Y |
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Sánchez José M, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
| Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax. Leukemia research 2022 9 122 106942. Bewersdorf Jan Philipp, Shallis Rory M, Derkach Andriy, Goldberg Aaron D, Stein Anthony, Stein Eytan M, Marcucci Guido, Zeidan Amer M, Shimony Shai, DeAngelo Daniel J, Stone Richard M, Aldoss Ibrahim, Ball Brian J, Stahl Maximili |
| A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
| BCR-ABL1 is a secondary event after JAK2V617F in a patient with essential thrombocythemia who develop chronic myeloid leukemia. Blood science (Baltimore, Md.) 2022 12 4 (4): 199-204. Zhang Yanqing, Bi Hailiang, Wang Ying, Chen Long, Pan Jiaqi, Xu Ping, Wang Wei, Yang Shaob |
| JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
- Page last reviewed:Feb 1, 2024
- Content source: